OZEMPIC, WEGOVY: THE SECRET ARM AGAINST TOO MANY KILOS? EVERYTHING ABOUT THE MEDICINAL OBESITY REVOLUTION
Did you know that almost 39% of adults worldwide struggle with overweight or obesity? Unexpected, but the future of the fight against those extra kilos seems to lie with a needle. Drugs like Ozempic and Wegovy are redefining traditional approaches to dieting and offering new hope. For whom? For whom? At what cost? Let’s explore this medical revolution together.
Drugs that are changing the game
The numbers are alarming. But science is stepping in, with breakthroughs like Ozempic, Wegovy, and Mounjaro. What are they based on? Molecules originally designed to treat diabetes, but now showing unexpected potential against obesity.
Ozempic, Wegovy and Mounjaro: what are they?
These names sound like promising solutions. Here are their key features:
Semaglutide: a molecule that mimics the GLP-1 hormones present in the gut.
Key actions: increased feeling of satiety and slowed gastric emptying.
Specific dosages: Wegovy (2.4 mg) targets severe obesity, while Ozempic (1 mg) focuses on diabetes.
The results? Spectacular. Up to 15% weight loss in 68 weeks.
Miracle solution or chemical dependency?
For those who have tried everything – from diets to surgery – these drugs could be the mysterious missing link. But then, is it a miracle, or should we worry about a new form of addiction?
EFFECTIVENESS THAT STUFFS SPECIALISTS
Finally, a treatment that exceeds the effectiveness of traditional methods? The specialists themselves are impressed.
The eye-opening figures
The clinical data are very revealing:
Average loss: between 12% and 15% of weight, comparable to the effects achieved by bariatric surgery.
Duration: in just over a year (68 weeks).
Related benefits: reduced cardiovascular risk for diabetics.
However, after a year, a plateau effect. And when treatment is stopped? Unfortunately, 70% of the weight lost returns.
SIDE EFFECTS NOT TO BE IGNORED
Evidently, every promise has its downside. These treatments come with dangers, and some profiles are more at risk than others.
What are the risks?
The main side effects are:
Severe: pancreatitis, intestinal obstruction, psychiatric disorders.
Rebound syndrome: euphoria followed by post-stop depression.
Esthetic: loss of facial fat known as “Ozempic face”.
And the cost? From 270 to 360 euros per month, with no reimbursement in France. A luxury that stings!
ENTRE SOCIAL ANGLE AND MEDICAL DERIVATIVES
These drugs, originally designed for serious pathologies, are being hijacked for purely cosmetic purposes. A phenomenon that provokes debate and concern.
Off-label prescribing and shortages
Off-label use: many non-diabetic patients take these treatments to lose weight fast.
Impact of social networks: influencers tout spectacular results… at what price?
Growing traffic: fake prescriptions, worrying shortages.
Finally, are we facing a revolution or a medical drift?
INEQUALITY OF ACCESS TO TREATMENT
Cost and reimbursement remain obstacles in most countries. Glaring differences depending on geographic location.
Comparison by country
| Countries | Monthly cost | Reimbursement | Accessibility | |
|---|---|---|---|---|
| France | 270-360 € | No | Very limited | |
| United States of America | .Unis | ~900 $ | Rare | Difficile |
| Europe (variable) | 300-700 € | Partial | Inégal | |
| Canada (Alberta) | Variable | Yes | Easier |
Can we really talk about medical justice with such discrepancies?
ALTERNATIVE: PREVENTION ALWAYS EXISTS
For those who prefer to avoid the needle, prevention remains an effective route. However, it requires a long-term commitment.
Hygieno-dieting: relearning how to eat properly.
Psychological support: coping with emotional eating disorders.
Bariatric surgery: for extreme cases.
Less revolutionary, yes, but sometimes more sustainable.
A CHANGE IN SOCIETAL PARADIGM
These treatments are not just medical tools; they symbolize a rethinking of the stigma around obesity.
Long-term monitoring: essential for measuring lasting effects.
Recurrence prevention: the real post-treatment challenge.
Changing attitudes: towards comprehensive, non-judgmental care.
Essentials to remember
Who can consider these treatments?
Those with severe obesity (BMI >35) or associated pathologies.
What are the keys to success?
A rigorous medical follow-up, accompanied by a complementary lifestyle.
Long-term efficacy: what to remember?
Promising in the short term, but watch out for recurrences.
Prevention: always a must
Eat health, exercise, and emotional support.
No longer let the pounds determine your daily life. Change is in your hands.
